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Abstract 
  This article analyzes the strengths and weaknesses of the existing global health care models 
and proposals for health care reform in the social protection system of Uzbekistan. 
 




The world has a great deal of experience in the development and optimization of health care 
financing models in social protection. Developed countries are making wise use of the health insurance 
system in order to expand the coverage of the population with free medical services, sources of funding, 
methods of distribution of funds, as well as to increase the efficiency and reduce costs in the health 
sector. 
 
RELEVANCE OF THE RESEARCH TOPIC 
The current health models in the world are not universal, in this regard, the strengths and 
weaknesses of the models, the analysis of the experience of foreign countries in this area play an 
important role in reforming and optimizing health in the social protection system of Uzbekistan. 
The purpose of the study. Development of scientific proposals and practical recommendations 
for the use of foreign experience in health insurance reform in the formation of the health insurance 
system in Uzbekistan. 
Research methods. The research process used grouping, abstract-logical thinking and 
comparative analysis. 
The main results. All models of health care systems in the world can be divided into three types: 
1. Budget model (government system) 
2. Insurance model (social insurance system) 
3. Private model (non-state or market system). 
A characteristic feature of the first model, known as the Beveridge model, is that the state takes 
the lead in this model. The main source of funding is tax revenues. Medical services are provided free of 
charge for the entire population. Typically, the share of health expenditures in GDP is 8-11 percent. 
Private insurance and surcharges play an important role. 
The main source of funding is the state budget, where health workers receive budget funds under 
the control of private management companies. The government plays the role of both a provider and a 
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user of medical services, providing the majority of health expenditures (more than 70%). Health system 
management is centralized. Most medical services are provided by public health facilities and private 
physicians, and private medical facilities are given a secondary place. 
The second model, known as the Bismarck model, is often defined as a regulated health 
insurance system. This model is based on the principles of a mixed economy, combined with an 
advanced system of state regulation of the market of medical services, social guarantees. When state-
funded insurance funds, compulsory health insurance programs cover the entire population and the state 
covers more than 70 percent of health care costs, and government spending on health care is higher than 
the budget model at 9-13 percent of GDP. Private nonprofits, commercial insurance funds and insurance 
companies play a crucial role in the distribution of funds. The role of the market in meeting the needs of 
the population for medical services is great, and patients have the freedom to choose insurance 
companies and service providers. 
The private model of health care deals with the provision of paid services at the expense of 
private insurance companies and citizens' own funds. The market plays a leading role in meeting the 
needs for medical services. In practice, the state assumes obligations that are not met by the market, ie 
covers the costs of providing medical services to citizens in need of social protection (unemployed, low-
income and pensioners). 
In the private model, more than 50 percent of funding is provided at the expense of citizens' own 
private funds. The funds will be collected in private insurance funds and directed to medical institutions. 
The provision of medical services is decentralized and is carried out by organizations based on different 
forms of ownership. 
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Figure 1. Classification of health care systems in developed countries 1 
Figure 1 below shows the classification of budget, insurance, and private models of the health 
care system in developed countries. 
On the social protection system - we analyze the experience of the United States, Germany, 
Great Britain, France and Canada. 
Germany is an example of the classic model of social insurance, the sources of funding of which 
are distributed as follows: social health insurance - 60%, private health insurance - 10%, the state 
budget - 15% and personal funds of citizens - 15%. Almost 90% of the German population is covered 
by social health insurance programs and 10% by private health insurance programs, while 3% of 
socially insured people have a voluntary health insurance policy. 
In Germany, the share of health expenditures in the country's GDP is 7.8-11.7%. 75% of health 
expenditures are covered from the state budget. The movement of health financing funds had the 
following appearance, they were first accumulated in the state fund of social health insurance, and then 
transferred to the accounts of non-profit insurance organizations that control the services of medical 
institutions. Physicians ’associations, known as hospital funds, form the basis of the social health 
insurance system. They create self-regulatory structures that manage the provision and financing of 
legally guaranteed services in compulsory health insurance. 
According to the World Health Organization, the incidence of various serious diseases in the 
country has significantly decreased in the last 2000-2019 due to the widespread use of health insurance 
in the financing of medical services in Germany. In particular, during the analyzed period, the incidence 
of ischemic heart disease decreased by 1.6 times, the incidence of vascular disease decreased by 1.7 
times (see Figure 2). According to international experts, due to the fact that the population of the 
country has health insurance policies, along with the expansion of access to health care, the quality of 
services is improving. As a result, the incidence of serious diseases and premature deaths is declining 
year by year.2 
 
                                                     
1Author construction 
2 Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2019. World Health 
Organization. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates 
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Figure 2. List of TOP-10 diseases that cause death in Germany (per 100,000 population) 3 
In Germany, from 2010 to 2014, the population's desire to use health insurance services 
increased significantly. As a result, during the period under review, the income of insurance funds 
began to increase. Due to the demographic aging problem in the country and the spread of new types of 
diseases, deaths, morbidity and various acquired disabilities, in 2010-2019 the share of insurance funds 
in the country to meet their obligations increased, and in 2017 the country's health insurance 
"Zinszusatzreserve ( ZZZ) ”method was put into practice. Using this method, a reduction in the cost of 
insurance funds was achieved (see Figure 3). This method consisted of making changes to the order of 
payment of various benefits and payments in the event of death. 
 
Figure 3. Development trends of the German health insurance market (in million euros).4 
In the UK budget model, 85% of health care costs are covered by the state budget, and 15% are 
covered by private health insurance. The funds are accumulated in the state budget, and transferred to 
self-regulatory organizations that manage the financing of treatment and prevention facilities. The form 
of centralized health management applies. Total government spending is 9.4% of GDP, of which 7.7% 
of GDP is spent on health. The population is covered by free medical services and there are almost no 
additional fees for medical services. For the able-bodied segment of the population, a fixed fee of £ 7.85 
per prescription applies. 
The state deals with the accreditation of doctors and medical preventive institutions, regulating 
the activities of doctors. Levels and prices of medical services are managed by trust funds for primary 
health care. There are currently 152 primary health care trust funds in the UK, which control 80% of the 
national health care budget. There are also 167 hospitals and 129 fund trusts in the UK, which provide 
the bulk of inpatient care in the UK. The United Kingdom has independent local health care systems in 
                                                     
3 Compiled by the author based on data from the World Health Organization 
https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death 
4 Compiled by the faculty based on data from the German Federal Financial Services Agency. 
https://www.bafin.de/EN/PublikationenDaten/Datenbanken/Datenbanken_node_en.html 
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Scotland, Wales and Northern Ireland.5.  
 
Figure 4. List of TOP-10 diseases that cause death in the UK (per 100,000 population)6 
According to international experts, in the practice of financing the health care system in the UK, 
along with health insurance services, the establishment of trust funds provides an opportunity to 
increase the coverage of medical services to the population. As a result, between 2000 and 2019, the 
country achieved a reduction in morbidity and mortality from various serious diseases. In particular, the 
incidence of ischemic heart disease, which is the leading cause of death in the study period, decreased 
by about 2.2 times, vascular diseases - by 1.9 times, and the incidence of lower respiratory tract 
infections - by 1.8 times (see Figure 4). 
In the United States, there is a private model of health care, and there is no national system that 
covers the entire population. The U.S. is the only developed country where state guarantees in the field 
of health care apply only to a limited range of citizens and where access to health care is partially 
available. The leading source of funding is private insurance, which covers more than 50% of the cost 
of medical services. Other sources include programs for the elderly and low-income citizens, as well as 
personal funds of citizens. Management of funding for treatment and prevention facilities and private 
physicians remains in the hands of private health insurance companies. The state manages the 
distribution of resources through special government programs for citizens in need of social protection. 
The management of the national health system is decentralized. The share of total government 
expenditures in GDP is 17.2%, of which health expenditures from social sources account for 9.1% of 
GDP. Provision of access to medical services is limited by patients ’ability to pay. Social programs for 
the elderly and the poor do not apply to the socially vulnerable and almost do not cover the medical 
services needed. Nearly 50 million people receive no medical care at all. 
In U.S. practice, the implementation of health insurance programs and the increase in the 
                                                     
5Kullman D. PHIS Pharma Profile United Kingdom (http://whocc.goeg.at/Literaturliste/Dokumente/ 
CountryInformationReports/PHIS%20Pharma%20Profile%20UK%20Feb2011.pdf). 
6 Compiled by the author based on data from the World Health Organization 
https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death 
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coverage of medical services to the population, as well as the prevention of the occurrence of certain 
types of life-threatening diseases. In particular, between 2000 and 2019, the number of deaths due to 
ischemic heart disease in the country decreased by 1.4 times, vascular diseases by 1.3 times, and deaths 
from lung cancer by 1.2 times. It also completely prevented the occurrence of deaths due to lower 
respiratory tract infections and breast cancer (see Figure 5).7 
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Figure 5. List of TOP-10 diseases that cause death in the United States (per 100,000 
population)8 
Analyzes show that the total amount allocated to health care varies from country to country. The 
fact that the life expectancy of the population and other health indicators are not proportional to the 
amount spent, which, firstly, shows the differences in the efficiency of spending, and secondly, shows 
that other factors affect the life expectancy of the population. It can be observed in the example of life 
expectancy and expenditure of the population in developed countries analyzed in Table 1. 
Table 1 
The effectiveness of the cost-benefit ratio in the health system 9 
Country  Life expectancy 
Share of health expenditures in 
the country's GDP% 
Health expenditures per 
capita, (in U.S. dollars)  
United States 78,6 17,2 8608 
Germany 80,7 11,7 4875 
United Kingdom 80,8 9,4 3609 
France 81,7 12,5 4952 
Канада 80,9 10,8 5630 
 
                                                     
7 Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2019. World Health 
Organization. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates 
8 Compiled by the author based on data from the World Health Organization 
https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death 
9Most Efficient Health Care: Countries / Bloomberg Visual Data (http://www.bloomberg.com/visual-data/ 
best-and-worst/most-efficient-health-care-countries). 
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A comparative analysis of the performance of the health care system in the world practice allows 
to draw the following scientific conclusions about the advantages and disadvantages of health models 
(see Table 2): 
- countries do not use only one model of social protection and there is no universal model; 
- All models of health care have a leading source of funding; 
- The state provides more than 70% of the costs of the budget and insurance models; 
- An important factor in ensuring the sustainability of the health care system is the coverage of the 
population with free medical services, resource efficiency and access to health services. 
- The development of the health care system in the country is impossible without insurance 
payments without the state budget. 
In world practice, health insurance is compulsory for employees, in developed countries, 
compulsory health insurance is the financial basis of the health care system. 
The organization of the global health insurance system is well developed, and the leading source 
of funding for the health care system is health insurance funds. Government and insurance companies 
are actively involved in this process. Each country is financed from the state budget and health 
expenditures through compulsory health insurance. 
Table 2 














































France 11,5 4958,99 80 State 13,6 66/34 
 
The World Health Organization has published the "International Health Rankings" for 2020 by 
regions of the world. In calculating the results of this rating, the organization's experts made an assessment 
                                                     
10 http://ifmr.uz/возможности-и-перспективы-развития-м/.  
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of 100 points and used the following system of 13 indicators:11 
- Legal framework of the health care system and the practice of financing medical services; 
- coordination and centralization of medical services; 
- food security; 
- condition and level of development of laboratory rooms of medical service institutions; 
- Cases of zoonotic diseases (infectious diseases of animals); 
- control over the quality and scope of medical services; 
- The level of staffing of the health system and their potential; 
- the level of emergency preparedness of the health care system and medical institutions; 
- types of medical services provided to the population and their quality; 
- prevention of the spread of infectious diseases; 
- The level of incidence of new diseases; 
- The impact of chemical phenomena on natural and environmental processes; 
- level of preparedness for radionuclide emergencies. 
 
Figure 6. Health System Rating by Region of the World, 2019.12 
Based on the above indicators, according to a study conducted by experts from the World Health 
Organization, in 2019 the ranking of the global health system was 63. In the regions of Africa (44) and 
Southeast Asia (61), this figure was lower than the world average (see Figure 6). 
Due to the widespread use of health insurance in the provision of health services in most EU 
countries, the legal framework for health system rankings and health care financing practices in the region 
(80), coordination and centralization of health care (82), quality and scope of health care. components such 
as control (79), types of medical services provided to the population and their quality (79) are high (see 
Table 3). It should be noted that the rating on the American continent is averaged for South and North 
America, while the regional index is relatively lower than the European Union. However, health insurance 
services in this region are also considered to have been introduced voluntarily in the United States and 
Canada. 
Conclusions and suggestions. It is important to make a comparative analysis of the rich experience 
of development of the health insurance system in the system of social protection in foreign countries, to 
                                                     
11 Based on data from the World Health Organization https://www.who.int/data/gho/whs-2020-visual-summary 
12 Compiled by the author based on data from the World Health Organization https://www.who.int/data/gho/whs-2020-
visual-summary 
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study the issues of social protection of the population in Uzbekistan, the creative application of health 
insurance in the health system. The study of the accumulated rich, advanced foreign experience in the health 
system will allow to identify priorities for the development of the local health system. Foreign experience 
shows that in countries with a high level of state participation in the medical sector, they often improve the 
quality of medical care and increase life expectancy. 
At the same time, the private sector should be developed, taking into account the level of income of 
the population, the demographic situation and the availability of financing for the health insurance system. A 
minimum list of medical services that everyone has access to, regardless of their financial or legal status in 
the community, should be guaranteed. 
Table 3 

























































Legal framework of the health care system 
and the practice of financing medical 
services 
43 74 67 80 64 76 65 
Coordination and centralization of medical 
services 
51 78 69 82 74 72 70 
Cases of zoonotic diseases (infectious 
diseases of animals) 
50 72 58 80 77 65 67 
Food security 43 78 53 77 64 75 64 
Condition and level of development of 
laboratory rooms of medical service 
institutions 
56 79 73 81 69 81 72 
Controlling the quality and scope of 
medical care 
61 78 78 79 72 84 73 
The level of staffing of the health system 
and their potential 
49 70 60 71 64 68 63 
The level of emergency preparedness of 
the health care system and medical 
institutions 
40 73 58 73 65 75 62 
Types of medical services provided to the 
population and their quality 
41 64 61 79 68 70 62 
Prevent the spread of infectious diseases 43 68 71 66 60 69 60 
The level of incidence of new types of 36 70 53 60 64 70 56 
                                                     
13 Compiled by the author based on data from the World Health Organization https://www.who.int/data/gho/whs-2020-
visual-summary 
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Influence of chemical phenomena on 
natural-ecological processes 
32 60 45 69 56 70 54 
Радионуклеар фавқулодда вазиятларга 
тайёргарлик даражаси 
32 59 45 77 57 54 55 
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